Rome, 23 March (beraking latest news Salute) – Sputnik is welcome but there is a need for further study. This is the view of the virologist Andrea Crisanti who, as a guest of ‘Tagadà’ on La7, brakes the escapes forward. “Sputnik is similar in conception to AstraZeneca and Johnson & Johnson, therefore – explains Crisanti – I am not surprised that this vaccine is fictional. Part of the data has been published in a very important international magazine and they are all in all convincing – he underlines -. I think at this moment in time. there is a need for in-depth analysis and verification. I imagine that the data are already available to the EMA, which is evaluating them. Therefore, it is a process that is maturing “.
As for the scarce availability of vaccines, Crisanti is clear: “The question had to be resolved when the States gave the money to the manufacturers. America gave a billion and 250 million dollars to Moderna and secured the production. almost total of this vaccine. It is clear that – says Crisanti – when the contracts were made and the public money was given, some clauses had to be put in place for sharing the technologies that were not made. is that you can say ‘you have a patent and I’ll take it off’, because it would be an expropriation. The best thing would have been to reach compromises to relocate production “.
But the technologies underlying mRna vaccines (Pfizer and Moderna) are new, “still to be discovered and potentially – Crisanti emphasizes – with immense value. So I understand well the reluctance of pharmaceutical companies not to want to share the patent”.
That said, adds the virologist, to solve the problems of this pandemic worldwide “it will not be the vaccines, neither Moderna nor Pfizer because these are basically vaccines for the rich. Countries with limited economic resources – explains Crisanti – such as African ones cannot afford vaccines. the kind that need a cold chain at those levels. ”
COPYRIGHT today © breaking latest news